At a glance
ClinicalIndex Comparison RecordN/ACompleted· 85 enrolled
Drug / intervention
CHTP 1.0 +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.0 (CHTP 1.0) Compared to Continuing to Use Conventional Cigarettes During 5 Days in Confinement.
In Brief
A clinical study evaluating CHTP 1.0 and Conventional Cigarette (CC) for Smoking. Completed, enrolled 85 participants across 1 site.
Detailed Summary
The overall goal of the study is to demonstrate the reduction of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) in adult smokers switching for 5 days from conventional cigarette (CC) to Carbon Heated Tobacco Product 1.0 (CHTP 1.0) as compared to smokers continuing to use CC.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesPoland
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedJul 2015
Primary CompletionSep 2015
Study CompletionMar 2016
TodayJul 2026
First PostedJul 20, 2015
Enrollment StartJul 1, 2015
Primary CompletionSep 1, 2015
Study CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.0 years ago
Interventions
CHTP 1.0other
CHTP 1.0 ad libitum for 5 days in confinement
Conventional Cigarette (CC)other
Subject's own preferred brand of CC ad libitum for 5 days in confinement